Eduardo Salcedo, MD
Undersea and Hyperbaric Medicine · Odessa, TXNPI 1114955812
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $739 of the $839 with a category attached, or 88.1%. 10 manufacturers reported payments, led by Kowa Pharmaceuticals America, Inc. at 35.7% of the total. 2025 is the largest year on record at $283, 2.6 times the $110 reported in 2019. That places this record below the midpoint for undersea and hyperbaric medicine clinicians in TX, where the typical reported total is $844.
Across 46 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Pharmaceuticals America, Inc.$300
- AbbVie$127
- Smith+Nephew$122
- Incyte Corporation$100
- Veran Medical Technologies, Inc.$58
- Amgen$41
- plus $91 from 4 others
What the payments were for
- Food & beverage$73988%
- Education$10012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 22 | $300 |
| AbbVie | 6 | $127 |
| Smith+Nephew | 8 | $122 |
| Incyte Corporation | 1 | $100 |
| Veran Medical Technologies, Inc. | 1 | $58 |
| Amgen | 3 | $41 |
| Lifenet Health | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
How this compares
$839 in reported general payments places this provider in the 45th percentile of 59 undersea and hyperbaric medicine providers in Texas.
See all undersea and hyperbaric medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 64 | $3,817 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 83 | $3,470 |
| Ketoconazole | 221 | $3,216 |
| Betamethasone Dipropionate | 79 | $3,022 |
| Triamcinolone Acetonide | 110 | $1,581 |
| Mupirocin | 130 | $980 |
| Gentamicin Sulfate | 29 | $978 |
| Doxycycline Hyclate | 46 | $621 |
| Clindamycin Phosphate | 24 | $569 |
| Fluconazole | 51 | $537 |
| Ammonium Lactate | 13 | $321 |
| Doxycycline Monohydrate | 15 | $298 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $194 |
| Ciprofloxacin Hcl | 27 | $160 |
| Clindamycin Hcl | 21 | $149 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Odessa
- Wade FarrowCollege Station$2.2M
- Timothy BumannAbilene$154K
- Heather AguirreSan Antonio$98K
- Ronald ScottFrisco$76K
- Andrew ApplewhiteDallas$46K
- Joseph WolcottLubbock$38K
- Noel OliveiraEdinburg$33K
- Maria AguinagaMission$18K
- Jayesh ShahSan Antonio$17K
- Marcus GitterleNew Braunfels$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.